Valentin Huerva

Lleida, CT 25198, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Evaluation of Intraocular Lens Power Calculation Formulas for Highly Myopic Eyes: A Systematic Review and Network Meta-Analysis.

Evaluation of Intraocular Lens Power Calculation Formulas for Highly Myopic Eyes: A Systematic Review and Network Meta-Analysis.

Journal: Journal of clinical medicine

Published: June 19, 2026

Immunocryosurgery as Primary Treatment for Lentigo Maligna and as an Adjuvant Therapy for Lentigo Maligna Melanoma: A 21-Patient Case Series.

Immunocryosurgery as Primary Treatment for Lentigo Maligna and as an Adjuvant Therapy for Lentigo Maligna Melanoma: A 21-Patient Case Series.

Journal: Dermatology (Basel, Switzerland)

Published: March 26, 2026

Response to Comment on: Accuracy of 12 IOL power calculation formulas in highly myopic eyes.

Response to Comment on: Accuracy of 12 IOL power calculation formulas in highly myopic eyes.

Journal: International ophthalmology

Published: October 08, 2025

Impact of Diabetic Peripheral Neuropathy on Corneal Sensitivity and Ocular Surface.

Impact of Diabetic Peripheral Neuropathy on Corneal Sensitivity and Ocular Surface.

Journal: Ophthalmic research

Published: September 25, 2025

Accuracy of 12 IOL power calculation formulas in highly myopic eyes.

Accuracy of 12 IOL power calculation formulas in highly myopic eyes.

Journal: International ophthalmology

Published: March 23, 2025

Topical Insulin for Ocular Surface Disease.

Topical Insulin for Ocular Surface Disease.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

Published: March 25, 2024

Accuracy of 10 IOL power calculation formulas in 100 short eyes (≤ 22 mm).

Accuracy of 10 IOL power calculation formulas in 100 short eyes (≤ 22 mm).

Journal: International ophthalmology

Published: November 17, 2022

Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis.

Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis.

Journal: Case reports in ophthalmology

Published: November 10, 2022

Undesirable High Astigmatism after Penetrating Keratoplasty in Pseudophakia Corrected with an Add-On Toric Intraocular Lens.

Undesirable High Astigmatism after Penetrating Keratoplasty in Pseudophakia Corrected with an Add-On Toric Intraocular Lens.

Journal: Case reports in ophthalmology

Published: October 05, 2022

Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.

Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.

Journal: Survey of ophthalmology

Published: October 21, 2021

Adjunctive Treatment with Interferon Alpha 2b in Conjunctival Melanoma.

Adjunctive Treatment with Interferon Alpha 2b in Conjunctival Melanoma.

Journal: Ocular oncology and pathology

Published: October 18, 2021

IgG4-related orbital disease.

IgG4-related orbital disease.

Journal: Canadian journal of ophthalmology. Journal canadien d'ophtalmologie

Published: December 15, 2020

Showing 1-12 of 60

Last Updated: 09/26/2026